Top compounds associated with response to AAMDC


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.004 0.9
mRNA tosedostat CTRPv2 pan-cancer AAC 0.058 0.1
mRNA tivozanib CTRPv2 pan-cancer AAC -0.0069 0.9
mRNA tivozanib GDSC1000 pan-cancer AAC 0.04 0.2
mRNA tivantinib CTRPv2 pan-cancer AAC -0.05 0.3
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.056 0.07
mRNA tigecycline CTRPv2 pan-cancer AAC -0.034 0.5
mRNA thapsigargin gCSI pan-cancer AAC -0.089 0.1
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.065 0.07
Download CSV